Inquis Medical has reported that the trial of its Aventus thrombectomy system for pulmonary embolism (PE) met its primary ...

Core has completed the acquisition of neurotechnology solution provider NeuroMetrix, including its Quell platform.

The FDA designation is a step forward for Neuralink as owner Elon Musk faces increasing scrutiny. The US Food and Drug ...

HeartBeam’s synthesised 12-lead ECG has met the clinical endpoints in the VALID-ECG pivotal study, assessing ...

Canada’s UHN and U of T researchers have created a skin-based test that identifies progressive supranuclear palsy (PSP) ...

The FDA has approved Edwards Lifesciences' SAPIEN 3 TAVR platform for the treatment of patients with asymptomatic severe ...

Hilo (formerly known as Aktiia), has raised $42m in an oversubscribed Series B funding round, bringing its total funding to ...

The London Cancer Hub has been identified as a key district for ‘frontier innovation’ by London Mayor Sadiq Khan.

The US FDA has approved Element Science’s premarket approval (PMA) application for its Jewel Patch Wearable Cardioverter ...

LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) ...

Neurogen Biomarking has announced a collaboration with NeuroX to support patients’ journey on its brain health care ecosystem ...

The US Food and Drug Administration (FDA) has cleared OcuSciences’ retinal health assessment device, the OcuMet Beacon.